All Issue

2021 Vol.2, Issue 4 Preview Page

Review article

31 December 2021. pp. 144-148
Abstract
Sorry, not available.
Click the PDF button.
References
1
Wawer MJ et al., Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda, The Journal of infectious diseases, 2005 10.1086/42941115809897
2
Vernazza P et al., Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle, Bull Méd Suisse, 2008
3
Rodger AJ et al., Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy, JAMA, The journal of the American Medical Association, 2016 10.1001/jama.2016.514827404185
4
Grant RM et al., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, The New England journal of medicine, 2010
5
Molina JM et al., On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection, The New England journal of medicine, 2015
6
McCormack S et al., Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, Lancet, 2016
7
Krakower D et al., What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review, Ann Intern Med, 2012 10.7326/0003-4819-157-7-201210020-0051022821365PMC3790586
8
Marrazzo JM et al., Tenofovir-based preexposure prophylaxis for HIV infection among African women, The New England journal of medicine, 2015
9
Korean Society for A. Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea, Infect Chemother, 2017
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 2
  • No :4
  • Pages :144-148